VUONG NGUYEN: Open Payments
NPI 1053400986 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,054 in 42 payments from 11 companies in 2025. Trend: 2023 $4,280 · 2024 $4,026 · 2025 $1,054
Food & beverage: $1,054
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $261 |
| Neurocrine BioSciences, Inc. | 5 | $142 |
| Janssen Pharmaceuticals, Inc | 6 | $139 |
| Vanda Pharmaceuticals Inc. | 6 | $124 |
| ABBVIE INC. | 3 | $75 |
| Lundbeck LLC | 3 | $74 |
| Alkermes, Inc. | 4 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $34 |
Products named: CAPLYTA, INGREZZA, SPRAVATO, FANAPT, REXULTI, VRAYLAR, ARISTADA, COBENFY.
Industry payments across CA — which companies pay providers there.
